Clinical management of low ovarian response to stimulation for IVF: a systematic review.
about
Glucocorticoid supplementation during ovarian stimulation for IVF or ICSIDifferent ovarian stimulation protocols for women with diminished ovarian reserveComparison of different stimulation protocols used in in vitro fertilization: a reviewGrowth hormone and reproduction: a review of endocrine and autocrine/paracrine interactionsLow-dose aspirin for in vitro fertilization: a systematic review and meta-analysisAdded value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approachAnalysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patientsComparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian RespondersComparison of GnRh Agonist Microdose Flare Up and GnRh Antagonist/Letrozole in Treatment of Poor Responder Patients in Intra Cytoplaspic Sperm Injection: Randomized Clinical TrialMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.Is there a recommended maximum starting dose of FSH in IVF?Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilizationEffect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria."Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial.Toll-like receptors expression in follicular cells of patients with poor ovarian responseDiscordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.LH pretreatment as a novel strategy for poor responders.Enough is enough! Patients who do not conceive on 600 IU/d of gonadotropins show no improvement from an additional 150 IU of LH activity.A systematic review of tests predicting ovarian reserve and IVF outcome.Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.Lipid profiling of follicular fluid from women undergoing IVF: young poor ovarian responders versus normal responders.Live birth and cumulative live birth rates in expected poor ovarian responders defined by the Bologna criteria following IVF/ICSI treatment.Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial.Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges.Different ovarian response by age in an anti-Müllerian hormone-matched group undergoing in vitro fertilization.What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?Role of the nonhuman primate for research related to women's health.Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilizationLive birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation studyThe assesment of follicular fluid presepsin levels in poor ovarian responder womenandits relationship with the reproductive outcomes.Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.Female and male lifestyle habits and IVF: what is known and unknown.C-type natriuretic peptide stimulates ovarian follicle development.Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.Pharmacogenetics of controlled ovarian hyperstimulation.Should endometriomas be treated before IVF-ICSI cycles?Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.Use of oral contraceptives in infertile patients: A descriptive review.Oocyte-derived R-spondin2 promotes ovarian follicle development.
P2860
Q24247518-0A201FDE-9D91-43E0-BBBC-F00DB2D632F7Q24634342-DCFD5D8C-425E-44D6-9BF4-78AE95A70676Q26799866-0AAAED12-034A-4235-99DF-A659BDAA70E7Q28082801-2A26B387-8268-42BB-BF1E-3670C7373041Q28220366-0C8D486F-A1F7-426C-90B2-E97BB1EAC46EQ28280088-E647D6AF-607D-4F48-9B19-43F918776BB2Q28831019-78E04E60-0883-4AA5-AA78-B9555557BEE9Q28831445-83FE0D76-C6AE-4DC0-AC65-2DA44BA3B4B5Q28833755-2AB7430B-32F6-4805-B358-F8036897DF60Q30399747-66DB75A2-DA93-40FA-93D8-C90AA83C3CA6Q33287991-2AE8BFE4-816B-47DD-BFA0-FB7B735F68EEQ33751962-E5707813-6BB2-4A89-995C-7C7E4CF2D91EQ33763516-FAE85EC3-3D09-4B00-A3A9-D943786D1062Q33897168-04BBB5C9-42E3-4321-BE38-ACA4967959E5Q33937289-D19CF510-59C0-4F16-AC09-E43A5B72B279Q33952002-71C71E3B-F164-4D1E-B50F-E452AE42D09EQ34092900-8586AB88-09EF-4CBD-9CA6-E495B9BC2B08Q34420111-71B75AE1-82EE-49B4-B6DC-61087ECADC5EQ34554644-9668FE71-C324-43D8-B9D4-EBDC08C78A71Q34608174-93B92C08-6E1F-4AA2-AF8B-1B6EB2D8C86EQ35057481-3ABA491B-E0EB-4A8D-95D6-F40B8F71AD76Q35154524-A394AECC-F557-4506-AB90-B17CA8FFF070Q35204428-166F014E-A971-4FC3-BCB8-07B76AAA6EF6Q35711752-BC514710-C19A-4C81-B19F-560AA8310B81Q35722615-C6967CFA-0D7B-45ED-B36A-D79F1B6B2581Q35750252-CEEF456B-2DAC-412C-98C9-39067F1469E9Q35757584-61444E6F-D955-4D30-A9EC-7AEC6AD96FB6Q35782737-5CDBFD89-BF8E-4333-9BD8-A56AA3198127Q35816235-EBA1F63E-6D54-4A20-B7F7-F6853768C652Q35959022-8FA90B46-995D-41C4-8779-70ACC5249F04Q35994080-75E052D8-B8C1-4844-89E5-6B93156F84B9Q36040101-98ED801A-2B6D-4FF7-8ADF-7C42E6E63FFEQ36065498-05BDF08F-0F3B-4A27-9C55-C23356F5D1B9Q36192094-1B30C089-1C4D-404A-94B9-8641603AF3A7Q36249242-05BF1A2F-830F-48FA-B54F-4C1B5E65F353Q36254681-7C9F6968-854C-43D4-8FC1-9011C86A35A3Q36270580-C2BAFC2D-ED9C-4BB0-8BFB-A891B58E92F5Q36529952-E39C2EFE-A779-440D-9E05-01C5C478BA76Q36668521-ED2C7D35-58AD-477D-BBCB-1029ABFA98AEQ36860325-F64B4893-6157-4BA9-A0B1-5F28DE3E464C
P2860
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@ast
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@en
type
label
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@ast
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@en
prefLabel
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@ast
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@en
P2093
P356
P1476
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
@en
P2093
Grimbizis G
Tarlatzis BC
Zepiridis L
P356
10.1093/HUMUPD/DMG007
P577
2003-01-01T00:00:00Z